Insufficient scRNA-seq data for expression of CCKBR at single-cell level.
Insufficient scRNA-seq data for expression of CCKBR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 82% | 812.54 | 2164 / 2642 | 54% | 4.44 | 383 / 705 |
pancreas | 97% | 584.14 | 318 / 328 | 33% | 2.20 | 58 / 178 |
stomach | 96% | 2838.19 | 343 / 359 | 17% | 1.52 | 50 / 286 |
ovary | 3% | 4.14 | 6 / 180 | 45% | 2.10 | 192 / 430 |
thymus | 2% | 1.91 | 14 / 653 | 28% | 0.70 | 172 / 605 |
prostate | 8% | 11.70 | 19 / 245 | 16% | 0.43 | 80 / 502 |
uterus | 2% | 4.39 | 4 / 170 | 18% | 2.69 | 83 / 459 |
skin | 15% | 18.10 | 268 / 1809 | 5% | 0.32 | 25 / 472 |
esophagus | 8% | 13.71 | 116 / 1445 | 9% | 0.61 | 17 / 183 |
intestine | 3% | 6.67 | 30 / 966 | 8% | 0.45 | 40 / 527 |
breast | 0% | 0.44 | 2 / 459 | 10% | 1.48 | 114 / 1118 |
lung | 0% | 1.09 | 1 / 578 | 9% | 0.75 | 105 / 1155 |
kidney | 0% | 0 | 0 / 89 | 7% | 0.17 | 62 / 901 |
adrenal gland | 2% | 4.00 | 6 / 258 | 4% | 0.25 | 10 / 230 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.31 | 3 / 45 |
bladder | 0% | 0 | 0 / 21 | 4% | 0.60 | 21 / 504 |
liver | 0% | 0 | 0 / 226 | 2% | 0.07 | 9 / 406 |
adipose | 0% | 2.30 | 4 / 1204 | 0% | 0 | 0 / 0 |
heart | 0% | 0.14 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0001696 | Biological process | gastric acid secretion |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0048732 | Biological process | gland development |
GO_0045851 | Biological process | pH reduction |
GO_0038188 | Biological process | cholecystokinin signaling pathway |
GO_0048565 | Biological process | digestive tract development |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005886 | Cellular component | plasma membrane |
GO_0015054 | Molecular function | gastrin receptor activity |
GO_0004951 | Molecular function | cholecystokinin receptor activity |
GO_0017046 | Molecular function | peptide hormone binding |
GO_0031741 | Molecular function | type B gastrin/cholecystokinin receptor binding |
GO_0005515 | Molecular function | protein binding |
GO_0046935 | Molecular function | 1-phosphatidylinositol-3-kinase regulator activity |
Gene name | CCKBR |
Protein name | Gastrin/cholecystokinin type B receptor (CCK-B receptor) (CCK-BR) (Cholecystokinin-2 receptor) (CCK2-R) Cholecystokinin B receptor splice variant long isoform Cholecystokinin B receptor Cholecystokinin B receptor splice variant hip/hop2 Cholecystokinin B receptor splice variant hip/hop1 Cholecystokinin B receptor splice variant hip/hop3 Gastrin/cholecystokinin type B receptor (Cholecystokinin-2 receptor) |
Synonyms | CCKRB |
Description | FUNCTION: Receptor for gastrin and cholecystokinin. The CCK-B receptors occur throughout the central nervous system where they modulate anxiety, analgesia, arousal, and neuroleptic activity. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system.; FUNCTION: Isoform 2 is constitutively activated and may regulate cancer cell proliferation via a gastrin-independent mechanism. FUNCTION: Receptor for gastrin and cholecystokinin. The CCK-B receptors occur throughout the central nervous system where they modulate anxiety, analgesia, arousal, and neuroleptic activity. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. . FUNCTION: Receptor for gastrin and cholecystokinin. The CCK-B receptors occur throughout the central nervous system where they modulate anxiety, analgesia, arousal, and neuroleptic activity. This receptor mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. . |
Accessions | A0SEH4 ENST00000525014.1 ENST00000525462.1 [P32239-2] E9PJ49 A0SEH5 A0SEH6 A0SEH7 ENST00000531712.5 ENST00000532715.5 E9PPL7 P32239 ENST00000334619.7 [P32239-1] E9PIC8 |